44 related news articles for Cancer Genetics and Functional Genomics

At Hudson Institute, Minister for Medical Research Ben Carroll announced the establishment of the Victorian Paediatric Cancer Consortium Limited (VPCC Ltd), made possible by a $35 million investment from the Government and $10 million from the Children’s Cancer Foundation.…  Read more

Cancer remains the number-one disease-related killer of Australian children, so a new program at Hudson Institute of Medical Research has been established to specifically target one of the most deadly cancers – sarcoma.…  Read more

The Childhood Cancer Model Atlas leverages AI and global collaboration to accelerate treatments for paediatric solid and CNS tumours.…  Read more

A deadly form of children’s brain cancer that’s immune to chemotherapy is the target of new research at Hudson Institute, looking at the epigenome and immuno-therapies for answers.…  Read more

Exciting research projects covering healthier pregnancy, safer birth and new forms of cancer treatment have attracted major funding in the form of NHMRC Investigator grants.…  Read more

Hudson Institute’s Research Committee has announced this year’s recipients of the Science Innovation Seed Funding Awards.…  Read more

When it comes to treating disease, the medical profession is increasingly recognising that children are not just small adults: their bodies behave differently. …  Read more

Congratulations to the recipients of the 2023 Harold Mitchell Travel Fellowships, provided by the Harold Mitchell Foundation to give young scientists much-needed opportunities for to expand their horizons.…  Read more

The future of children with cancer is brighter today, with the announcement of significant funding from the Victorian government for paediatric cancer research.…  Read more

It’s hard to imagine four words more frightening to a parent than “Your child has cancer”. Amid the fear and panic such a sentence creates, three-year-old Luca’s parents, Monique and Baden, had little choice but to trust in the best that medical science could offer.…  Read more

A single laboratory in south-east Melbourne is now the global hub for medical researchers looking to cure childhood cancer.…  Read more

Congratulations to Professor Ron Firestein, who was announced this week as Deputy Director of Hudson Institute of Medical Research.…  Read more

Two new candidates have been identified as crucial factors in maintaining good intestinal health.…  Read more

Hudson Institute researchers have featured prominently among the latest recipients of NHMRC Ideas Grants.…  Read more

Two Hudson Institute researchers at different stages of their careers have won sought-after Victorian Cancer Agency (VCA) Fellowships. Blood cancer specialist Dr Catherine Carmichael received the VCA Mid-Career Research Fellowship for her research into Acute Myeloid Leukaemia (AML), while Dr Claire Sun was awarded the VCA Early Career Research Fellowship to further her search for…  Read more

As a global leader in the field of childhood cancer research, Hudson Institute of Medical Research welcomes the Victorian Government’s pledge to invest $35 million in this area of vital need.…  Read more

A world-class Melbourne collaboration is set to beat the worst childhood cancers. …  Read more

For clinicians, detecting cancer is a victory in itself, but stopping its spread is crucial to a successful outcome. For Professor Ron Firestein, 2021 brought welcome results in that endeavour, thanks to the discovery that disabling two proteins together robs bowel cancer cells of their ability to express genes necessary for growth and spread.…  Read more

Hudson Institute of Medical Research is proud to be a recipient in the latest round of funding from the Ovarian Cancer Research Foundation (OCRF).…  Read more

Hudson Institute was proud to host the announcement of the Victorian Paediatric Cancer Consortium (VPCC).…  Read more

A colon cancer research breakthrough at Hudson Institute has shown that combining two types of drugs targeting gene expression stops cancer proliferation.…  Read more

An ambitious project to identify and characterise the rarest and deadliest forms of brain cancer in children has received a welcome funding boost.…  Read more

Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.…  Read more

Drugs that are being trialled to treat leukaemia could also be used to fight bowel cancer after a breakthrough by Hudson Institute of Medical Research scientists.…  Read more

Ten Hudson Institute PhD students have been selected for the second year running to participate in the high-level mentoring program, Industry Mentoring Network in STEM (IMNIS).…  Read more

Congratulations to Dr Marius Dannappel and Dr Madara Ratnadiwakara who have been awarded The Ron Evans AM Fellowship to progress treatments for bowel cancer.…  Read more

Congratulations to the 2019 Hudson Institute Travel Awards recipients who will attend international conferences and visit laboratories to build invaluable knowledge in their area of research.…  Read more

More than 150 leading clinicians and scientists heard from national and international experts in childhood cancer at Hudson Institute of Medical Research on Wednesday, 13 February at a highly anticipated international symposium. The symposium was made possible through the generous support of our premium partner, the Children’s Cancer Foundation, along with the Isabella and Marcus…  Read more

Hudson Institute’s Cancer Genetics and Functional Genomics Postdoctoral Scientist, Dr Marius Dannappel, has been awarded a highly sought after Research Fellowship from the DFG (German Research Foundation) that will progress his research aimed at developing treatments for colorectal cancer. The two year early career fellowship will enable Dr Dannappel to continue his research into the…  Read more

A collection of data extracted from more than 1000 paediatric brain tumour samples will improve Hudson Institute scientists’ ability to tackle childhood brain cancer through targeted therapies. The new Paediatric Brain Tumour Atlas (PBTA), launched by the US-based Children’s Brain Tumour Tissue Consortium (CBTTC) on Monday, includes data collected from 30 unique childhood brain tumour…  Read more

Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.…  Read more

A new PhD scholars program in paediatric cancer precision medicine has been established at Hudson Institute of Medical Research with co-funding from the Children’s Cancer Foundation. The program will train the next generation of scientists in advanced functional and structural genomics, development of patient-centric preclinical models, bioinformatics analytics and translational research with the aim of…  Read more

‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and gastric cancers, are being developed in Clayton, Melbourne, thanks to almost $3 million in Federal Government funding awarded to lead participant Cartherics Pty Ltd. Hudson Institute of Medical Research and Monash University researchers are partnering with industry leaders in cell therapies to develop…  Read more

Precision medicine is providing new hope for patients with ovarian cancer, the most common cause of death from gynaecological cancers. Only 3 out of every 10 women diagnosed with advanced stage ovarian cancer will survive after five years. These statistics haven’t improved in 30 years, but precision medicine approaches are opening up new possibilities. While…  Read more

The Hudson Monash Precision Medicine Program hopes to significantly improve treatment for childhood cancer patients with the greatest unmet clinical need – those diagnosed with brain cancers and solid tumours. Launched today (February 7) ahead of International Childhood Cancer Day on February 15, the two year program is being established with a $1.3 million investment…  Read more

A cutting-edge CRISPR library containing more than 36,000 molecular scissors targeting every known gene in the human genome is realising the clinical potential of precision medicine research at Hudson Institute. Hudson Institute scientists now have access to the award-winning Merck/Sanger Arrayed Whole Genome CRISPR Library on-site at the Monash Health Translation Precinct. Associate Professor Ron…  Read more

Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer. Hudson Institute has been announced as the first Australian member of the US-based Children’s Brain Tumor Tissue Consortium (CBTTC) and joins a collaborative, multi-institutional research program dedicated to the study and…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

Targeted genetic treatment for cancer is a step closer, with a world-first clinical trial set to test the effectiveness of a new class of drugs called BET inhibitors in treating prostate and colorectal cancer. A team of clinicians and researchers at Hudson Institute of Medical Research and Monash University has been awarded a $2 million…  Read more

The Australian Minister for Health, the Hon Sussan Ley MP, has officially opened the Translational Research Facility at the Monash Health Translation Precinct (MHTP) yesterday (Thursday, March 10). The new $84million Translational Research Facility brings together researchers, clinicians, and patients in an innovative collaboration that allows patient needs to better inform medical research. Bringing together the expertise…  Read more

A researcher from Hudson Institute of Medical Research in Melbourne has discovered a class of biomarkers which may be used to predict which cancer patients will respond to a new class of cancer drugs.…  Read more

Associate Professor Ron Firestein talks about why he moved from the US (where he worked for biotech company Genentech in San Francisco) to take up an appointment at the Hudson Institute as Director of the Centre for Cancer Research…  Read more

Hudson Institute has welcomed its newest head of the Centre for Cancer Research, Associate Professor Ron Firestein, who has relocated from San Francisco with his young family to take up the role.…  Read more